(Q40927590)
Statements
1 reference
A Phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line (English)
1 reference
Percheson PB
1 reference
Trépanier P
1 reference
Dugré R
1 reference
Mabrouk T
1 reference
1 January 1999
1 reference
1 reference
98
1 reference
127-32; discussion 133-4
1 reference
Identifiers
1 reference